Multiplex Assay Kit for Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay)

TRF; Siderophilin; Serotransferrin; Beta-1 metal-binding globulin

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-89 85
EDTA plasma(n=5) 81-91 85
heparin plasma(n=5) 81-97 87

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 92-99% 90-104% 81-92% 90-99%
EDTA plasma(n=5) 88-102% 95-103% 97-105% 78-101%
heparin plasma(n=5) 84-101% 82-103% 84-102% 96-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:TF) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS ONE Identification of Altered Plasma Proteins by Proteomic Study in Valvular Heart Diseases and the Potential Clinical Significance PubMed: PMC3754973
Physiological research The Labile Iron Pool in Monocytes Reflects the Activity of the Atherosclerotic Process in Men with Chronic Cardiovascular Disease pubmed:27782743
Journal of Proteomics Putative salivary biomarkers useful to differentiate patients with fibromyalgia Pubmed:29654921
Journal of Clinical Medicine Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients Pubmed: 30486327
The Nigerian postgraduate medical journal the official publication of the National Postgraduate Medical College of Nigeria Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria
Haematologica New thiazolidinones reduce iron overload in mouse models of hereditary hemochromatosis and β-thalassemia Pubmed: 30792208
Catalog No. Related products for research use of Sus scrofa; Porcine (Pig) Organism species Applications (RESEARCH USE ONLY!)
NPC036Po01 Native Transferrin (TF) Positive Control; Immunogen; SDS-PAGE; WB.
RPC036Po01 Recombinant Transferrin (TF) Positive Control; Immunogen; SDS-PAGE; WB.
PAC036Po01 Polyclonal Antibody to Transferrin (TF) WB; IHC; ICC; IP.
PAC036Po02 Polyclonal Antibody to Transferrin (TF) WB; IHC; ICC; IP.
LAC036Po81 FITC-Linked Polyclonal Antibody to Transferrin (TF) WB; IHC; ICC; IF.
LAC036Po71 Biotin-Linked Polyclonal Antibody to Transferrin (TF) WB; IHC; ICC.
MAC036Po21 Monoclonal Antibody to Transferrin (TF) WB; IHC; ICC; IP.
MAC036Po24 Monoclonal Antibody to Transferrin (TF) WB; IHC; ICC; IP.
MAC036Po25 Monoclonal Antibody to Transferrin (TF) WB; IHC; ICC; IP.
MAC036Po23 Monoclonal Antibody to Transferrin (TF) WB; IHC; ICC; IP.
MAC036Po22 Monoclonal Antibody to Transferrin (TF) WB; IHC; ICC; IP.
FAC036Po02 Anti-Transferrin (TF) Monoclonal Antibody Flow cytometry.
SEC036Po ELISA Kit for Transferrin (TF) Enzyme-linked immunosorbent assay for Antigen Detection.
CEC036Po ELISA Kit for Transferrin (TF) Enzyme-linked immunosorbent assay for Antigen Detection.
LMC036Po Multiplex Assay Kit for Transferrin (TF) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.